Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.

Article  PubMed  Google Scholar 

Chi ZS, Lee ET, Lu M, Bennett PH, Group tWMS. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44:82–S86.

Article  Google Scholar 

Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia 2006, 49(11):2580–2588.

van Susan D, Beulens JWJ, Yvonne T, van der Grobbee S, Nealb DE. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabilitation. 2010;17(1suppl):3–s8.

Article  Google Scholar 

Raghavan S, Vassy JL, Ho YL, Song RJ, Gagnon DR, Cho K, Wilson PWF, Phillips LS. Diabetes Mellitus–related all-cause and Cardiovascular Mortality in a national cohort of adults. J Am Heart Association 2019, 8(4).

Deng Y, Wu S, Liu J, Liu M, Wang L, Wan J, Zhang S, Liu M. The stress hyperglycemia ratio is associated with the development of cerebral edema and poor functional outcome in patients with acute cerebral infarction. Front Aging Neurosci 2022, 14.

Zhou Q, Yang J, Wang W, Shao C, Hua X, Tang Y-D. The impact of the stress hyperglycemia ratio on mortality and rehospitalization rate in patients with acute decompensated heart failure and diabetes. Cardiovasc Diabetol 2023, 22(1).

Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, Wang W, Shao C, Tang Y-D. The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with acute coronary syndrome: insight from a large cohort study in Asia. Diabetes Care. 2022;45(4):947–56.

Article  CAS  PubMed  Google Scholar 

Baker EH, Janaway CH, Phillips BJ, Brennan AL, Baines DL, Wood DM, Jones PW. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Shen H-C, Liang W-R, Ning M, Wang Z-X, Chen Y, Su W, Guo T-T, Hu K, Liu Y-W. Relationship between stress hyperglycemia ratio and allcause mortality in critically ill patients: results from the MIMIC-IV database. Front Endocrinol 2023, 14.

Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O’Dea H, Stranks SN, Burt MG, Doogue MP. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metabolism. 2015;100(12):4490–7.

Article  CAS  Google Scholar 

Song Y, Cui K, Yang M, Song C, Yin D, Dong Q, Gao Y, Dou K. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol 2023, 22(1).

Cui K, Fu R, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z et al. The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry. Cardiovasc Diabetol 2023, 22(1).

Karakasis P, Stalikas N, Patoulias D, Pamporis K, Karagiannidis E, Sagris M, Stachteas P, Bougioukas KI, Anastasiou V, Daios S et al. Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: a systematic review with bayesian and frequentist meta-analysis. Trends Cardiovasc Med 2023.

Zou X, Zhou X, Zhu Z, Ji L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 2019;7(1):9–11.

Article  PubMed  Google Scholar 

NHANES Survey Methods and Analytic Guidelines. https://www.ncdcgov/nchs/nhanes/analyticguidelinesaspx 2023.

Sia C-H, Chan MH-H, Zheng H, Ko J, Ho AF-W, Chong J, Foo D, Foo L-L, Lim PZ-Y, Liew BW et al. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients. Cardiovasc Diabetol 2021, 20(1).

Lin Z, Liang X, Zhang Y, Dai Y, Zeng L, Chen W, Kong S, He P, Duan C, Liu Y. Positive association between stress hyperglycemia ratio and pulmonary infection in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Cardiovasc Diabetol 2023, 22(1).

Zhang Y, Song H, Bai J, Xiu J, Wu G, Zhang L, Wu Y, Qu Y. Association between the stress hyperglycemia ratio and severity of coronary artery disease under different glucose metabolic states. Cardiovasc Diabetol 2023, 22(1).

Algül E, Özbeyaz NB, Şahan HF, Aydınyılmaz F, Sunman H, Tulmaç M. Stress hyperglycemia ratio is Associated with high Thrombus burden in patients with Acute Coronary Syndrome. Angiology 2023:000331972311670.

Liu J, Zhou Y, Huang H, Liu R, Kang Y, Zhu T, Wu J, Gao Y, Li Y, Wang C et al. Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from American MIMIC-IV and the Chinese CIN-II study. Cardiovasc Diabetol 2023, 22(1).

Xu W, Yang Y-m, Zhu J, Wu S, Wang J, Zhang H, Shao X. -h: predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study. Cardiovasc Diabetol 2022, 21(1).

Paolisso P, Bergamaschi L, Rambaldi P, Gatta G, Foà A, Angeli F, Fabrizio M, Casella G, Barbieri M, Galiè N, et al. Impact of admission hyperglycemia on heart failure events and mortality in patients with Takotsubo Syndrome at Long-Term Follow-up: data from HIGH-GLUCOTAKO investigators. Diabetes Care. 2021;44(9):2158–61.

Article  CAS  PubMed  Google Scholar 

SHAMOON HARRY, HENDLER ROSA. Synergistic interactions among Antiinsulin Hormones in the pathogenesis of stress hyperglycemia in humans. Clin Endocrinol Metab. 1981;52:1235–981.

Article  CAS  Google Scholar 

Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24(5):293–316.

Article  PubMed  Google Scholar 

Asfar P, Hauser B, Radermacher P, Matejovic M. Catecholamines and Vasopressin during critical illness. Crit Care Clin. 2006;22(1):131–49.

Article  CAS  PubMed  Google Scholar 

Monnier Louis M, Emilie G, Christine M, Francoise V, Laetitia. Cristol Jean-Paul, Colette Claude: activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemiain with type 2 diabetes. JAMA. 2006;295:1681–7.

Article  CAS  PubMed  Google Scholar 

Dungan Kathleen M, Braithwaite Susan S, Jean-Charles P. Stress hyperglycaemia. Lancet. 2009;373:1798–807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamamoto Y, Yamamoto H. RAGE-Mediated inflammation, type 2 diabetes, and Diabetic Vascular complication. Front Endocrinol 2013, 4.

Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JCM, Hoekstra JBL. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–9.

Article  CAS  PubMed  Google Scholar 

CEFALU WILLIAMT, DAVID J. SCHNEIDER HAROLDE, CARLSON, PHYLLIS MIGDAL, LEONIL GAN LIM MERIAMP, IZON, ANOOP KAPOOR, AUDREY BELL-FARROW JAMESG, TERRY, BURTON E. SOBEL: Effect of Combination Glipizide GITS/Metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 Diabetic subjects. Diabetes Care. 2002;25:2123–8.

Article  CAS  PubMed  Google Scholar 

Ferroni P, Basili S, Falco A, Davì G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost. 2004;2(8):1282–91.

Article  CAS  PubMed  Google Scholar 

AARON I. VINIK, TOMRIS ERBAS, TAE SUN PARK, ROGER NOLAN. PITTENGER: platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24:1476–85.

Article  Google Scholar 

CHARLES KODNER LA, KATHERINE POHLGEERS. Glucose management in hospitalized patients. Am Fam Physician. 2017;96(10):648–54.

Google Scholar 

Sophia Z, Anushka P, John C, de Galan E, Bastiaan L, Qiang MB, Laurent B et al. Woodward Mark, Ninomiya Toshiharu, Neal Bruce : Severe Hypoglycemia and Risks of Vascular Events and Death. N Engl J Med 2010, 363:1410–1418.

Zinman B, Marso SP, Christiansen E, Calanna S, Rasmussen S, Buse JB. Hypoglycemia, Cardiovascular outcomes, and death: the LEADER experience. Diabetes Care. 2018;41(8):1783–91.

Article  CAS  PubMed  Google Scholar 

Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340(jan08 1):b4909–9.

Article  PubMed  PubMed Central  Google Scholar 

Cha S-A, Yun J-S, Lim T-S, Hwang S, Yim E-J, Song K-H, Yoo K-D, Park Y-M, Ahn Y-B, Ko S-H. Severe Hypoglycemia and Cardiovascular or all-cause mortality in patients with type 2 diabetes. Diabetes Metabolism J. 2016;40(3):202.

Article  Google Scholar 

Qu F, Shi Q, Wang Y, Shen Y, Zhou K, Pearson ER, Li S. Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: a systematic review and meta-analysis. Chin Med J. 2022;135(19):2294–300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fadini GP. Perturbation of glucose homeostasis during Acute illness: stress hyperglycemia and relative hypoglycemia. Diabetes Care. 2022;45(4):769–71.

Article  CAS  PubMed  Google Scholar 

Kahal H, Halama A, Aburima A, Bhagwat AM, Butler AE, Graumann J, Suhre K, Sathyapalan T, Atkin SL. Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects. Sci Rep 2020, 10(1).

Yamamoto K, Ito T, Nagasato T, Shinnakasu A, Kurano M, Arimura A, Arimura H, Hashiguchi H, Deguchi T, Maruyama I et al. Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study. Thromb J 2019, 17(1).

Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J, Sheridan PJ, Heller SR. Risk of Cardiac Arrhythmias during hypoglycemia in patients with type 2 diabetes and Cardiovascular Risk. Diabetes. 2014;63(5):1738–47.

Article  CAS  PubMed  Google Scholar 

Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diab/Metab Res Rev. 2008;24(5):353–63.

Article  CAS  Google Scholar